岡田 玲緒奈 おかだ れおな 先生

来歴等

略歴

2010年 千葉大学医学部 卒業
2019年 千葉大学医学部附属病院 次世代医療構想センター 特任助教
2021年 千葉大学大学院卒業見込み 博士（医学）取得見込み
2021年 保健医療リテラシー推進社中 理事、こびナビ 幹事

論文

• 1. Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex (miR-139-5p and miR-139-3p) in Renal Cell Carcinoma. Biomedicines. 2020 Dec 12;8(12):599. doi: 10.3390/biomedicines8120599.

  Okada R, Goto Y, Yamada Y, Kato M, Asai S, Moriya S, Ichikawa T, Seki N.

• 2. Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma. Cells. 2019 Nov 28;8(12):1535. doi: 10.3390/cells8121535.

  Okada R, Koshizuka K, Yamada Y, Moriya S, Kikkawa N, Kinoshita T, Hanazawa T, Seki N.

• 3. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis. Int J Mol Sci. 2020 Sep 4;21(18):6459. doi: 10.3390/ijms21186459.

  Shimomura H, Okada R, Tanaka T, Hozaka Y, Wada M, Moriya S, Idichi T, Kita Y, Kurahara H, Ohtsuka T, Seki N.

• 4. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes. J Hum Genet. 2020 Nov 12. doi: 10.1038/s10038-020-00865-y. Online ahead of print.

  Shinden Y, Hirashima T, Nohata N, Toda H, Okada R, Asai S, Tanaka T, Hozaka Y, Ohtsuka T, Kijima Y, Seki N.

• 5. Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogenic Genes. Cancers (Basel). 2020 Sep 23;12(10):2731. doi: 10.3390/cancers12102731.

  Tanaka T, Okada R, Hozaka Y, Wada M, Moriya S, Satake S, Idichi T, Kurahara H, Ohtsuka T, Seki N.

• 6. FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p). Cells. 2020 Sep 11;9(9):2083. doi: 10.3390/cells9092083.

  Mizuno K, Tanigawa K, Nohata N, Misono S, Okada R, Asai S, Moriya S, Suetsugu T, Inoue H, Seki N.

• 7. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation. J Hum Genet. 2020 Nov;65(11):1019-1034. doi: 10.1038/s10038-020-0795-x.

  Wada M, Goto Y, Tanaka T, Okada R, Moriya S, Idichi T, Noda M, Sasaki K, Kita Y, Kurahara H, Maemura K, Natsugoe S, Seki N.

• 8. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner. Cancer Sci. 2020 Jul;111(7):2223-2233. doi: 10.1111/cas.14428.

  Aoki T, Takami M, Takatani T, Motoyoshi K, Ishii A, Hara A, Toyoda T, Okada R, Hino M, Koyama-Nasu R, Kiuchi M, Hirahara K, Kimura MY, Nakayama T, Shimojo N, Motohashi S.

• 9. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer. J Hum Genet. 2020 Aug;65(8):647-656. doi: 10.1038/s10038-020-0746-6.

  Kawagoe K, Wada M, Idichi T, Okada R, Yamada Y, Moriya S, Okubo K, Matsushita D, Arigami T, Kurahara H, Maemura K, Natsugoe S, Seki N.

学会発表

• 1. AACR 2020 総会 ポスター発表: Regulation of oncogenic targets by miR-99a-3p (the passenger strand of the miR-99a -duplex) in head and neck squamous cell carcinoma

SNS・ブログ等

• Twitter
  • Twitter：eireonaok
• その他メディア
  • こびナビ
  • youtube
  • youtube